pI: 4.3342 |
Length (AA): 156 |
MW (Da): 18691 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 2 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
1 | 156 | 1zso (A) | 1 | 156 | 99.99 | 0 | 1 | 2.17 | -1.75 |
1 | 156 | 1zso (A) | 1 | 156 | 99.99 | 0 | 1 | 2.2684 | -1.76 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | intra-erythrocytic - 24 hs, intra-erythrocytic - 32 hs, intra-erythrocytic - 48 hs, sporozoite, early ring, early trophozoite, late ring, late trophozoite, Ring. | Otto TD PlasmoDB Zanghi G |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | intra-erythrocytic - 0 hs, intra-erythrocytic - 8 hs, intra-erythrocytic - 16 hs, intra-erythrocytic - 40 hs, merozoite, early schizont, late schizont, Oocyst. | Otto TD PlasmoDB Zanghi G |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | Male Gametocyte. | Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | gametocyte, Female Gametocyte. | PlasmoDB Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 0-20% percentile | Sporozoite. | Zanghi G |
Lasonder E | Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes. Molecular insight into sex-specific processes and translational repression. |
Zanghi G | A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection. |
PlasmoDB | Data on upregulation of P. falciparum genes in different life cycle stages, combined from several microarray experiments available in PlasmoDB |
Otto TD | New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq. |
Ortholog group members (OG5_128549)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT4G32930 | hypothetical protein |
Babesia bovis | BBOV_I004060 | conserved hypothetical protein |
Candida albicans | CaO19.8972 | conserved hypothetical protein similar to N. crassa NCU08505.1, S. pombe SPBC2D10.03c and S. cerevisiae YCR090C |
Candida albicans | CaO19.1394 | conserved hypothetical protein similar to N. crassa NCU08505.1, S. pombe SPBC2D10.03c and S. cerevisiae YCR090C |
Caenorhabditis elegans | CELE_F46B6.12 | Protein F46B6.12 |
Cryptosporidium hominis | Chro.30197 | hypothetical protein |
Cryptosporidium parvum | cgd3_1630 | hypothetical protein |
Dictyostelium discoideum | DDB_G0270194 | DUF866 family protein |
Drosophila melanogaster | Dmel_CG4646 | CG4646 gene product from transcript CG4646-RB |
Echinococcus granulosus | EgrG_000153900 | protein of unknown function DUF866 eukaryotic |
Echinococcus multilocularis | EmuJ_000153900 | protein of unknown function DUF866, eukaryotic |
Giardia lamblia | GL50803_5568 | Hypothetical protein |
Homo sapiens | ENSG00000162384 | chromosome 1 open reading frame 123 |
Leishmania braziliensis | LbrM.12.0440 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_120370.1 | Eukaryotic protein of unknown function (DUF866), putative |
Leishmania infantum | LinJ.12.0370 | hypothetical protein, conserved |
Leishmania major | LmjF.12.0410 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.12.0410 | hypothetical protein, conserved |
Mus musculus | ENSMUSG00000028608 | RIKEN cDNA 0610037L13 gene |
Neospora caninum | NCLIV_041300 | C1orf123, related |
Oryza sativa | 4327927 | Os01g0565600 |
Plasmodium berghei | PBANKA_1363900 | conserved protein, unknown function |
Plasmodium falciparum | PF3D7_1351100 | conserved protein, unknown function |
Plasmodium knowlesi | PKNH_1249800 | conserved protein, unknown function |
Plasmodium vivax | PVX_083450 | conserved protein, unknown function |
Plasmodium yoelii | PY06217 | hypothetical protein |
Saccharomyces cerevisiae | YCR090C | hypothetical protein |
Schistosoma japonicum | Sjp_0203240 | IPR008584,Protein of unknown function DUF866, eukaryotic,domain-containing |
Schistosoma mansoni | Smp_050880 | hypothetical protein |
Trypanosoma brucei gambiense | Tbg972.1.2140 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.1.3390 | Eukaryotic protein of unknown function (DUF866), putative |
Trypanosoma congolense | TcIL3000_0_54820 | Eukaryotic protein of unknown function (DUF866), putative |
Trypanosoma congolense | TcIL3000_0_60080 | Eukaryotic protein of unknown function (DUF866), putative |
Trypanosoma cruzi | TcCLB.506529.669 | Eukaryotic protein of unknown function (DUF866), putative |
Trypanosoma cruzi | TcCLB.510889.340 | Eukaryotic protein of unknown function (DUF866), putative |
Toxoplasma gondii | TGME49_288910 | DUF866 domain-containing protein |
Theileria parva | TP02_0714 | hypothetical protein, conserved |
Trichomonas vaginalis | TVAG_414020 | conserved hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.1.3390 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.1.3390 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.1.3390 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.1.3390 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
TGME49_288910 | Toxoplasma gondii | Probably non-essential | sidik |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Type | Source | Notes |
---|---|---|
soluble recombinant protein | Structural Genomics for Pathogenic Protozoa (SGPP) | Pfal004331; Recombinant protein: full-length; Source: P falciparum; hypothetical protein, conserved ; |